Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging

Functional nanocarriers capable of transporting high drug contents without premature leakage and to controllably deliver several drugs are needed for better cancer treatments. To address this clinical need, gold cluster bovine serum albumin (AuNC@BSA) nanogates were engineered on mesoporous silica n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2016-05, Vol.229, p.183-191
Hauptverfasser: Croissant, Jonas G., Zhang, Dingyuan, Alsaiari, Shahad, Lu, Jie, Deng, Lin, Tamanoi, Fuyuhiko, AlMalik, Abdulaziz M., Zink, Jeffrey I., Khashab, Niveen M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 191
container_issue
container_start_page 183
container_title Journal of controlled release
container_volume 229
creator Croissant, Jonas G.
Zhang, Dingyuan
Alsaiari, Shahad
Lu, Jie
Deng, Lin
Tamanoi, Fuyuhiko
AlMalik, Abdulaziz M.
Zink, Jeffrey I.
Khashab, Niveen M.
description Functional nanocarriers capable of transporting high drug contents without premature leakage and to controllably deliver several drugs are needed for better cancer treatments. To address this clinical need, gold cluster bovine serum albumin (AuNC@BSA) nanogates were engineered on mesoporous silica nanoparticles (MSN) for high drug loadings and co-delivery of two different anticancer drugs. The first drug, gemcitabine (GEM, 40wt%), was loaded in positively-charged ammonium-functionalized MSN (MSN-NH3+). The second drug, doxorubicin (DOX, 32wt%), was bound with negatively-charged AuNC@BSA electrostatically-attached onto MSN-NH3+, affording highly loaded pH-responsive MSN-AuNC@BSA nanocarriers. The co-delivery of DOX and GEM was achieved for the first time via an inorganic nanocarrier, possessing a zero-premature leakage behavior as well as drug loading capacities seven times higher than polymersome NPs. Besides, unlike the majority of strategies used to cap the pores of MSN, AuNC@BSA nanogates are biotools and were applied for targeted red nuclear staining and in-vivo tumor imaging. The straightforward non-covalent combination of MSN and gold-protein cluster bioconjugates thus leads to a simple, yet multifunctional nanotheranostic for the next generation of cancer treatments. [Display omitted]
doi_str_mv 10.1016/j.jconrel.2016.03.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790930053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016836591630164X</els_id><sourcerecordid>1790930053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-ed92bcfcb295c63ec1f2b65c7a8e72262a070d2b940bbba79ef16b1aeb3be273</originalsourceid><addsrcrecordid>eNqNkV1rFDEUhoNY7Fr9CUouvehsk8xHdq5EilWhYC96H5KTM9MsmWRMZhb7Y_yvZtnVW4UDIZznPV8vIe8423LGu5v9dg8xJPRbUb5bVpdgL8iG72RdNX3fviSbkthVddf2l-R1znvGWFs38hW5FLKkeMM25NdDigu6UI3RWwp-zQumXIGeZ7R0whznmOKaaXbegaZBhzjrtDjwmOkQE31y4xO1aR2pj9q6MF5TvS4xxOkoG3ECt2jjAt7Y-DOm1ThwgUKsLHp3wPRc-GBpGeHgDpEu61SKukmPpdQbcjFon_Ht-b0ij3efH2-_Vvffv3y7_XRfQcv4UqHthYEBjOhb6GoEPgjTtSD1DqUQndBMMitM3zBjjJY9DrwzXKOpDQpZX5EPp7Jzij9WzIuaXAb0XgcsSygue9bXx-v9B7prmk7Iri1oe0IhxZwTDmpOZa_0rDhTRw_VXp09VEcPFatLsKJ7f26xmgntX9Uf0wrw8QRgOcnBYVIZHAZA6xLComx0_2jxG0tMtR4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784462765</pqid></control><display><type>article</type><title>Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Croissant, Jonas G. ; Zhang, Dingyuan ; Alsaiari, Shahad ; Lu, Jie ; Deng, Lin ; Tamanoi, Fuyuhiko ; AlMalik, Abdulaziz M. ; Zink, Jeffrey I. ; Khashab, Niveen M.</creator><creatorcontrib>Croissant, Jonas G. ; Zhang, Dingyuan ; Alsaiari, Shahad ; Lu, Jie ; Deng, Lin ; Tamanoi, Fuyuhiko ; AlMalik, Abdulaziz M. ; Zink, Jeffrey I. ; Khashab, Niveen M.</creatorcontrib><description>Functional nanocarriers capable of transporting high drug contents without premature leakage and to controllably deliver several drugs are needed for better cancer treatments. To address this clinical need, gold cluster bovine serum albumin (AuNC@BSA) nanogates were engineered on mesoporous silica nanoparticles (MSN) for high drug loadings and co-delivery of two different anticancer drugs. The first drug, gemcitabine (GEM, 40wt%), was loaded in positively-charged ammonium-functionalized MSN (MSN-NH3+). The second drug, doxorubicin (DOX, 32wt%), was bound with negatively-charged AuNC@BSA electrostatically-attached onto MSN-NH3+, affording highly loaded pH-responsive MSN-AuNC@BSA nanocarriers. The co-delivery of DOX and GEM was achieved for the first time via an inorganic nanocarrier, possessing a zero-premature leakage behavior as well as drug loading capacities seven times higher than polymersome NPs. Besides, unlike the majority of strategies used to cap the pores of MSN, AuNC@BSA nanogates are biotools and were applied for targeted red nuclear staining and in-vivo tumor imaging. The straightforward non-covalent combination of MSN and gold-protein cluster bioconjugates thus leads to a simple, yet multifunctional nanotheranostic for the next generation of cancer treatments. [Display omitted]</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2016.03.030</identifier><identifier>PMID: 27016140</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject><![CDATA[A549 Cells ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - chemistry ; Bovine serum albumin ; Cancer ; Cell Line ; Deoxycytidine - administration & dosage ; Deoxycytidine - analogs & derivatives ; Deoxycytidine - chemistry ; Doxorubicin - administration & dosage ; Doxorubicin - chemistry ; Drug Carriers - administration & dosage ; Drug Carriers - chemistry ; Drug Liberation ; Gold - administration & dosage ; Gold - chemistry ; Gold nanoclusters ; Humans ; Mesoporous silica nanoparticles ; Multi-drug delivery ; Nanocomposites - administration & dosage ; Nanocomposites - chemistry ; Nanoparticles - administration & dosage ; Nanoparticles - chemistry ; Neoplasms - diagnostic imaging ; Neoplasms - drug therapy ; Porosity ; Serum Albumin, Bovine - administration & dosage ; Serum Albumin, Bovine - chemistry ; Silicon Dioxide - administration & dosage ; Silicon Dioxide - chemistry]]></subject><ispartof>Journal of controlled release, 2016-05, Vol.229, p.183-191</ispartof><rights>2016</rights><rights>Copyright © 2016. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-ed92bcfcb295c63ec1f2b65c7a8e72262a070d2b940bbba79ef16b1aeb3be273</citedby><cites>FETCH-LOGICAL-c501t-ed92bcfcb295c63ec1f2b65c7a8e72262a070d2b940bbba79ef16b1aeb3be273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S016836591630164X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27016140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Croissant, Jonas G.</creatorcontrib><creatorcontrib>Zhang, Dingyuan</creatorcontrib><creatorcontrib>Alsaiari, Shahad</creatorcontrib><creatorcontrib>Lu, Jie</creatorcontrib><creatorcontrib>Deng, Lin</creatorcontrib><creatorcontrib>Tamanoi, Fuyuhiko</creatorcontrib><creatorcontrib>AlMalik, Abdulaziz M.</creatorcontrib><creatorcontrib>Zink, Jeffrey I.</creatorcontrib><creatorcontrib>Khashab, Niveen M.</creatorcontrib><title>Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Functional nanocarriers capable of transporting high drug contents without premature leakage and to controllably deliver several drugs are needed for better cancer treatments. To address this clinical need, gold cluster bovine serum albumin (AuNC@BSA) nanogates were engineered on mesoporous silica nanoparticles (MSN) for high drug loadings and co-delivery of two different anticancer drugs. The first drug, gemcitabine (GEM, 40wt%), was loaded in positively-charged ammonium-functionalized MSN (MSN-NH3+). The second drug, doxorubicin (DOX, 32wt%), was bound with negatively-charged AuNC@BSA electrostatically-attached onto MSN-NH3+, affording highly loaded pH-responsive MSN-AuNC@BSA nanocarriers. The co-delivery of DOX and GEM was achieved for the first time via an inorganic nanocarrier, possessing a zero-premature leakage behavior as well as drug loading capacities seven times higher than polymersome NPs. Besides, unlike the majority of strategies used to cap the pores of MSN, AuNC@BSA nanogates are biotools and were applied for targeted red nuclear staining and in-vivo tumor imaging. The straightforward non-covalent combination of MSN and gold-protein cluster bioconjugates thus leads to a simple, yet multifunctional nanotheranostic for the next generation of cancer treatments. [Display omitted]</description><subject>A549 Cells</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Bovine serum albumin</subject><subject>Cancer</subject><subject>Cell Line</subject><subject>Deoxycytidine - administration &amp; dosage</subject><subject>Deoxycytidine - analogs &amp; derivatives</subject><subject>Deoxycytidine - chemistry</subject><subject>Doxorubicin - administration &amp; dosage</subject><subject>Doxorubicin - chemistry</subject><subject>Drug Carriers - administration &amp; dosage</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Liberation</subject><subject>Gold - administration &amp; dosage</subject><subject>Gold - chemistry</subject><subject>Gold nanoclusters</subject><subject>Humans</subject><subject>Mesoporous silica nanoparticles</subject><subject>Multi-drug delivery</subject><subject>Nanocomposites - administration &amp; dosage</subject><subject>Nanocomposites - chemistry</subject><subject>Nanoparticles - administration &amp; dosage</subject><subject>Nanoparticles - chemistry</subject><subject>Neoplasms - diagnostic imaging</subject><subject>Neoplasms - drug therapy</subject><subject>Porosity</subject><subject>Serum Albumin, Bovine - administration &amp; dosage</subject><subject>Serum Albumin, Bovine - chemistry</subject><subject>Silicon Dioxide - administration &amp; dosage</subject><subject>Silicon Dioxide - chemistry</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV1rFDEUhoNY7Fr9CUouvehsk8xHdq5EilWhYC96H5KTM9MsmWRMZhb7Y_yvZtnVW4UDIZznPV8vIe8423LGu5v9dg8xJPRbUb5bVpdgL8iG72RdNX3fviSbkthVddf2l-R1znvGWFs38hW5FLKkeMM25NdDigu6UI3RWwp-zQumXIGeZ7R0whznmOKaaXbegaZBhzjrtDjwmOkQE31y4xO1aR2pj9q6MF5TvS4xxOkoG3ECt2jjAt7Y-DOm1ThwgUKsLHp3wPRc-GBpGeHgDpEu61SKukmPpdQbcjFon_Ht-b0ij3efH2-_Vvffv3y7_XRfQcv4UqHthYEBjOhb6GoEPgjTtSD1DqUQndBMMitM3zBjjJY9DrwzXKOpDQpZX5EPp7Jzij9WzIuaXAb0XgcsSygue9bXx-v9B7prmk7Iri1oe0IhxZwTDmpOZa_0rDhTRw_VXp09VEcPFatLsKJ7f26xmgntX9Uf0wrw8QRgOcnBYVIZHAZA6xLComx0_2jxG0tMtR4</recordid><startdate>20160510</startdate><enddate>20160510</enddate><creator>Croissant, Jonas G.</creator><creator>Zhang, Dingyuan</creator><creator>Alsaiari, Shahad</creator><creator>Lu, Jie</creator><creator>Deng, Lin</creator><creator>Tamanoi, Fuyuhiko</creator><creator>AlMalik, Abdulaziz M.</creator><creator>Zink, Jeffrey I.</creator><creator>Khashab, Niveen M.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160510</creationdate><title>Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging</title><author>Croissant, Jonas G. ; Zhang, Dingyuan ; Alsaiari, Shahad ; Lu, Jie ; Deng, Lin ; Tamanoi, Fuyuhiko ; AlMalik, Abdulaziz M. ; Zink, Jeffrey I. ; Khashab, Niveen M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-ed92bcfcb295c63ec1f2b65c7a8e72262a070d2b940bbba79ef16b1aeb3be273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>A549 Cells</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Bovine serum albumin</topic><topic>Cancer</topic><topic>Cell Line</topic><topic>Deoxycytidine - administration &amp; dosage</topic><topic>Deoxycytidine - analogs &amp; derivatives</topic><topic>Deoxycytidine - chemistry</topic><topic>Doxorubicin - administration &amp; dosage</topic><topic>Doxorubicin - chemistry</topic><topic>Drug Carriers - administration &amp; dosage</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Liberation</topic><topic>Gold - administration &amp; dosage</topic><topic>Gold - chemistry</topic><topic>Gold nanoclusters</topic><topic>Humans</topic><topic>Mesoporous silica nanoparticles</topic><topic>Multi-drug delivery</topic><topic>Nanocomposites - administration &amp; dosage</topic><topic>Nanocomposites - chemistry</topic><topic>Nanoparticles - administration &amp; dosage</topic><topic>Nanoparticles - chemistry</topic><topic>Neoplasms - diagnostic imaging</topic><topic>Neoplasms - drug therapy</topic><topic>Porosity</topic><topic>Serum Albumin, Bovine - administration &amp; dosage</topic><topic>Serum Albumin, Bovine - chemistry</topic><topic>Silicon Dioxide - administration &amp; dosage</topic><topic>Silicon Dioxide - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Croissant, Jonas G.</creatorcontrib><creatorcontrib>Zhang, Dingyuan</creatorcontrib><creatorcontrib>Alsaiari, Shahad</creatorcontrib><creatorcontrib>Lu, Jie</creatorcontrib><creatorcontrib>Deng, Lin</creatorcontrib><creatorcontrib>Tamanoi, Fuyuhiko</creatorcontrib><creatorcontrib>AlMalik, Abdulaziz M.</creatorcontrib><creatorcontrib>Zink, Jeffrey I.</creatorcontrib><creatorcontrib>Khashab, Niveen M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Croissant, Jonas G.</au><au>Zhang, Dingyuan</au><au>Alsaiari, Shahad</au><au>Lu, Jie</au><au>Deng, Lin</au><au>Tamanoi, Fuyuhiko</au><au>AlMalik, Abdulaziz M.</au><au>Zink, Jeffrey I.</au><au>Khashab, Niveen M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2016-05-10</date><risdate>2016</risdate><volume>229</volume><spage>183</spage><epage>191</epage><pages>183-191</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><abstract>Functional nanocarriers capable of transporting high drug contents without premature leakage and to controllably deliver several drugs are needed for better cancer treatments. To address this clinical need, gold cluster bovine serum albumin (AuNC@BSA) nanogates were engineered on mesoporous silica nanoparticles (MSN) for high drug loadings and co-delivery of two different anticancer drugs. The first drug, gemcitabine (GEM, 40wt%), was loaded in positively-charged ammonium-functionalized MSN (MSN-NH3+). The second drug, doxorubicin (DOX, 32wt%), was bound with negatively-charged AuNC@BSA electrostatically-attached onto MSN-NH3+, affording highly loaded pH-responsive MSN-AuNC@BSA nanocarriers. The co-delivery of DOX and GEM was achieved for the first time via an inorganic nanocarrier, possessing a zero-premature leakage behavior as well as drug loading capacities seven times higher than polymersome NPs. Besides, unlike the majority of strategies used to cap the pores of MSN, AuNC@BSA nanogates are biotools and were applied for targeted red nuclear staining and in-vivo tumor imaging. The straightforward non-covalent combination of MSN and gold-protein cluster bioconjugates thus leads to a simple, yet multifunctional nanotheranostic for the next generation of cancer treatments. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27016140</pmid><doi>10.1016/j.jconrel.2016.03.030</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2016-05, Vol.229, p.183-191
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_1790930053
source MEDLINE; Elsevier ScienceDirect Journals
subjects A549 Cells
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - chemistry
Bovine serum albumin
Cancer
Cell Line
Deoxycytidine - administration & dosage
Deoxycytidine - analogs & derivatives
Deoxycytidine - chemistry
Doxorubicin - administration & dosage
Doxorubicin - chemistry
Drug Carriers - administration & dosage
Drug Carriers - chemistry
Drug Liberation
Gold - administration & dosage
Gold - chemistry
Gold nanoclusters
Humans
Mesoporous silica nanoparticles
Multi-drug delivery
Nanocomposites - administration & dosage
Nanocomposites - chemistry
Nanoparticles - administration & dosage
Nanoparticles - chemistry
Neoplasms - diagnostic imaging
Neoplasms - drug therapy
Porosity
Serum Albumin, Bovine - administration & dosage
Serum Albumin, Bovine - chemistry
Silicon Dioxide - administration & dosage
Silicon Dioxide - chemistry
title Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T17%3A20%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein-gold%20clusters-capped%20mesoporous%20silica%20nanoparticles%20for%20high%20drug%20loading,%20autonomous%20gemcitabine/doxorubicin%20co-delivery,%20and%20in-vivo%20tumor%20imaging&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Croissant,%20Jonas%20G.&rft.date=2016-05-10&rft.volume=229&rft.spage=183&rft.epage=191&rft.pages=183-191&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2016.03.030&rft_dat=%3Cproquest_cross%3E1790930053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1784462765&rft_id=info:pmid/27016140&rft_els_id=S016836591630164X&rfr_iscdi=true